Product review

The Phoenix Review: $879 for an Investigational Therapy, Self-Administered

The trials used focused shockwaves from clinic machines under an operator. This is a handheld you point at yourself. The FDA has not cleared it for erectile dysfunction, and the AUA calls the therapy investigational.

By EDTG editorialUpdated 02 AUG 20266 min read

Our score

2.6

Not FDA-cleared for EDNot a paid partner

What it is: No drug. A handheld device delivering acoustic pressure waves, intended to prompt new blood vessel growth in penile tissue
Regulatory status: Not FDA-cleared for ED
Sizes and models: One device with applicator heads, Self-administered protocol of repeated home sessions
Best for: Very few people. Men with confirmed vasculogenic ED who have exhausted evidence-based options and can afford to lose $879.

Key takeaways

Not FDA-cleared to treat erectile dysfunction, whatever the phrase 'within FDA-cleared ranges' is doing in the marketing.
The AUA guideline classes low-intensity shockwave therapy as investigational — for research protocols, not routine care.
The trials used focused shockwaves; consumer handhelds generally produce radial pressure waves. Different physics, non-transferable evidence.
$879 with no clinician screening you for implants, bleeding disorders, Peyronie's or lesions.
The same money buys roughly twenty years of generic tadalafil, which is guideline first-line treatment.

What else buys the same result

The closest thing that does the same job for the money: $879, against roughly twenty years of generic tadalafil or two medical-grade vacuum devices.

Compare the total cost →

✓ Pros

One-off purchase, cheaper than a course of in-office shockwave sessions
No drugs, so no interactions — including none with nitrates
Reusable indefinitely, so per-use cost falls over time
No prescription, consultation or subscription
The underlying idea — prompting new blood vessel growth — is a legitimate research direction

✕ Cons

**Not FDA-cleared to treat erectile dysfunction.** 'Within FDA-cleared ranges' is not the same claim
**The AUA guideline classes low-intensity shockwave therapy as investigational**, to be used under research protocols
Consumer handhelds generally produce **radial pressure waves**, not the **focused shockwaves** used in the trials
$879 with nobody assessing whether you are even a candidate
Unlikely to help post-surgical or severe neurogenic ED, where the mechanism does not apply
Contraindications — implants, bleeding disorders, Peyronie's, lesions — are screened by nobody
The money buys roughly twenty years of a treatment that is guideline first-line

Score breakdown

Clinical quality: 2.0
Transparency: 2.0
Value: 2.2
Experience: 3.5
Privacy: 4.0

Pricing

Plan	Price	What is included
The Phoenix	About $879	Device, applicator heads, instructions. One-off purchase
On promotion	Around $704	Frequently discounted. Financing quoted around $29–$43 a month
In-office shockwave, for scale	$400–$600 per session, usually six or more	Focused shockwaves, trained operator, clinical assessment. Still investigational, rarely covered
Generic tadalafil, for scale	About $20–$40 for 90 days	Guideline first-line, strong evidence, roughly 1/40th the price

Prices in this category change frequently and the renewal rate often differs from the introductory offer. Verify on the provider’s own site before buying.

Our verdict

This is the lowest score on the site, and the reason is a stack of gaps that each sound survivable and are not. Start with the therapy itself. Low-intensity shockwave treatment for erectile dysfunction is not established care — the AUA guideline places it in the investigational category and advises it be offered under research protocols, because although the mechanism is plausible, the trials are small, short, inconsistent in protocol, and weaker when properly sham-controlled. That is the evidence for the clinic version, delivered by a trained operator with a machine costing thousands. Now the technical point the marketing never addresses: those studies used **focused shockwaves**, generated and aimed to deposit a defined energy density at a defined depth. Consumer handhelds in this price bracket generally produce **radial pressure waves**, which spread from the surface and lose energy rapidly with depth. They are different physical phenomena, and evidence for one is not evidence for the other. Then the regulatory layer. The Phoenix is not FDA-cleared to treat erectile dysfunction. Copy about energy output staying 'within safe, FDA-cleared ranges for acoustic therapy' is a sentence engineered to be heard as clearance without ever making the claim. Add it up: $879, spent with nobody assessing whether you are a candidate or whether an implant, a bleeding disorder or Peyronie's rules you out, on a home version of a therapy still investigational in clinics. If you have genuinely exhausted the evidence-based options, understand exactly what you are buying, and can lose the money without it mattering, that is your call to make and we are not going to pretend otherwise. For nearly everyone else, $879 is about twenty years of generic tadalafil.

The premise, which is not stupid

Start with what is genuinely appealing here, because the pitch is not nonsense and the review would be unfair without it. Almost every ED treatment manages the symptom: a tablet dilates vessels for a few hours, a pump produces an erection now, a ring holds one. None changes the underlying tissue. The proposition behind shockwave therapy is that acoustic energy applied to penile tissue triggers a healing response including angiogenesis — the growth of new blood vessels. If that worked reliably it would be the first widely available treatment that repaired the plumbing rather than working around it.

That is a real research direction with published studies behind it, and our shockwave therapy page sets out where the evidence stands. In short: some trials show benefit, concentrated in men with vasculogenic ED who still respond partially to PDE5 inhibitors; the studies are mostly small and short with inconsistent protocols; sham-controlled results are weaker than open-label ones; and durability beyond a year is poorly established.

Focused versus radial: the distinction that decides it

'Shockwave' and 'acoustic wave' are used interchangeably in marketing. In physics, and in the trials, they are not interchangeable — and this is the single most useful thing on this page.

Two different things sold under similar names
	Focused shockwave	Radial pressure wave
How it is generated	Electrohydraulic, electromagnetic or piezoelectric, then focused to a point	A projectile striking an applicator, spreading outward from the surface
Energy at depth	Concentrated at a defined focal depth	Highest at the skin, falling away rapidly with depth
Used in the published ED trials	Yes	Largely not
Typical setting	Clinic, trained operator, machine costing thousands	Consumer handhelds and physiotherapy massage guns

Manufacturers do not reliably state which type their device produces. If a product page does not say plainly, that omission is informative.

If the mechanism depends on delivering particular energy to tissue at depth, and a device delivers something weaker that dissipates near the surface, trials of the first tell you very little about the second. The marketing bridges that gap by discussing shockwave therapy in general and then selling a handheld. The evidence does not bridge it.

What the FDA has and has not said

This matters beyond pedantry. Clearance for an indication is the mechanism by which somebody outside the company checks that a claimed benefit is supported. Without it, the only quality control on the claim is the company making it. When a device is sold for a use it has not been authorised for, you are the trial — and you are paying to be in it.

Where the $879 could go instead

Opportunity cost is the strongest argument here — stronger than any objection to the hardware. Money spent on an investigational home treatment is money not spent on options with settled evidence, and in this field the proven ones are cheap.

What $879 buys elsewhere
Instead	Roughly	Evidence
Generic tadalafil, daily, for years	$20–$40 per 90 days	Strong — guideline first-line
Medical-grade vacuum device	$130 one-off	Strong — around 90% achieve a usable erection
Urology consultation and workup	$150–$400 cash	Finds the cause rather than guessing at it
Sex therapy, several sessions	$100–$250 each	Strong for psychogenic and mixed ED
Pelvic floor physiotherapy	$80–$200 per session	Randomised trial evidence, particularly for venous leak

US cash prices, which vary widely. Model your own with the cost calculator.

The narrow case for buying one anyway

We are not going to pretend nobody should ever buy this. There is a narrow set of circumstances where it is a defensible decision, and stating them is fairer than leaving the page as a wall of objections.

You have vasculogenic ED confirmed by a clinician, rather than post-surgical nerve damage or a hormonal cause. That is the only group the published benefit has appeared in.
You have already tried PDE5 inhibitors — they help partially, or you cannot take them.
You understand that you are buying something investigational, and will not conclude that treatment has failed you when it does not work.
$879 is money you can lose, not money moved from something you need.
You have told a clinician you are doing it, so it is on your record if a problem arises.

FAQ

Frequently asked questions

Is The Phoenix FDA approved?

No. No low-intensity shockwave device is FDA-approved or cleared to treat erectile dysfunction in the US, including clinic machines. Language about staying 'within FDA-cleared ranges for acoustic therapy' is not a clearance for treating ED, and it is worded to be heard as one.

Does at-home shockwave therapy work for ED?

There is no good evidence that a consumer handheld does. The trials used focused shockwaves delivered by clinic machines, and even that use is classed as investigational by the AUA. Consumer devices generally produce radial pressure waves, which are physically different and lose energy near the surface, so the trial results do not transfer.

How much does it cost?

About $879, frequently discounted to around $704, with financing quoted at roughly $29 to $43 a month. One-off purchase with nothing recurring.

Is it cheaper than going to a clinic?

Yes — in-office sessions run $400 to $600 each and a course is usually six or more. But that comparison assumes both deliver the same treatment, and the evidence that a handheld matches a focused clinical device is missing. A cheaper version of an unproven therapy is not a bargain.

Who should not use it?

Anyone with a penile implant, an active infection, a bleeding disorder or on anticoagulants without advice, Peyronie's disease or an unassessed penile lesion, or a cancer diagnosis involving the area. Nobody in this purchase screens for any of that, which is the core problem with the model.

Will it cure my ED permanently?

Nothing on this site cures ED permanently, and durability of shockwave benefit beyond a year is poorly established even in the clinical studies. Treat permanent-cure claims with scepticism wherever you meet them.

What should I do instead?

Get assessed, because ED is often the first sign of vascular disease. Then work through the options with settled evidence — PDE5 inhibitors, a vacuum device, pelvic floor training, sex therapy, and treating the underlying cause. All cost less than $879 and all have better evidence.

Sources

What this is based on

We link to primary sources — clinical guidelines, regulator publications and peer-reviewed research — wherever possible. Links open on third-party sites we do not control.

[01]American Urological Association. Erectile Dysfunction: AUA Guideline (2018).
[02]U.S. Food and Drug Administration. Device registration and listing — what it does and does not mean.
[03]National Library of Medicine. ClinicalTrials.gov — find studies you can join.
[04]National Library of Medicine. PubMed — search the primary literature.
[05]Federal Trade Commission. Health Products Compliance Guidance.

★ Giveaway

One reader gets the sublingual treatment we rate highest for speed, free for a full year — a $2,100 prize, at $175 a month. Enter with your email below.

Not medical advice:This article is general information. Talk to a licensed clinician about your own situation. Full disclaimer.

Ad disclosure:We earn a commission if you buy through some links on this page, at no extra cost to you. How this works.